Therapeutic Areas/Disease States: 

Hemophilia 

Budget: $100,000 - $125,000

Intended Audience:

• Physicians (Hematologists / Hemophilia Specialists)
• Nurses
• Other Hemophilia Treatment Center Team Members
• Patients / Caregivers
• Managed Care

Bayer Hematology Rationale for Educational Support: 

Areas of interest based on referenced literature:

• Pediatric Hemophilia A: The Importance of Early Factor VIII Use in Young Pediatric Patients, Supporting Comprehensive Treatment Plans and Managing Lifestyle Variability into Adolescence

Accredited Proposal Requirements:

The proposal must be compliant with standards and guidelines for commercial support (e.g., ACCME). 
All supporting documents should be in PDF format and the proposal should include:

• Needs assessment
• Educational design and rationale for selection
• Learning Objectives
• Proposed Faculty
• Participant Recruitment Plan
• Outcomes Strategy/plan
• Definition of Successful Program
• Detailed Budget

Provider Justification: 

1. Copy of most recent accreditation letter and status
2. Samples of other programs in similar therapeutic areas

Process 

Applications/proposals which are submitted and determined to be complete are reviewed monthly.

Acceptance of a Bayer educational grant indicates that you will:

• Reconcile grant funding within 60 days of completion of the educational program
• Permit a Bayer Medical Affairs representative to audit live programs of at least $5000 (Bayer Compliance staff may also audit live programs and/or review the use of the grant)
• Share activity data and outcomes metrics within 30 days of their availability

Literature/Data Referenced 

1. Srivastava, A., et al. (2020) Haemophilia, 26(Suppl 6), 1-20
2. Srivastava, A., et al. (2020) Haemophilia, 26(Suppl 6), 1-158
3. Poonnoose, P. M., et al. (2018) Journal of Pediatric Hematology/Oncology, 40(4), 275-280
4. Whelan, M. A., & Kessler, C. M. (2019) Journal of Thrombosis and Haemostasis, 17(1), 15-22
5. O'Mahony, B., et al. (2019) Blood Reviews, 34, 1-10
6. Lee, C. A., et al. (2019) Pediatrics, 143(6), e20193444
7. Kearney, S. R., et al. (2021) Pediatrics, 147(6), e2021050571
8. Hoots, W. K., et al. (2020) Blood Reviews, 40, 100628
9. Manco-Johnson, M. J., et al. (2016) New England Journal of Medicine, 374(21), 2054-2064
10. Fischer, K., et al. (2018) Blood, 131(18), 2034-2041